Physician profile
John Wright
NPI 1992745913
$1,183,009.33
in general payments reported to CMS, 2019-2025
15 companies · $42K in 2025
The $42K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264K · 2020: $31K · 2021: $713K · 2022: $49K · 2023: $20K · 2024: $64K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Travel and Lodging: $26K · Food and Beverage: $1,182 · Long Term Medical Supply Or Device Loan: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,212.50 |
| Travel and Lodging | $26,001.43 |
| Food and Beverage | $1,181.68 |
| Long Term Medical Supply Or Device Loan | $243.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $904,361.69 | 2019-2022 | |
| Stryker Corporation | $277,666.54 | 2019-2025 | Mako, Aequalis, Verasense |
| Musculoskeletal Transplant Foundation INC. | $246.19 | 2021 | |
| Integra Lifesciences Corporation | $243.70 | 2023 | Acell |
| Medical Device Business Services, INC. | $109.22 | 2019 | |
| Depuy Synthes Sales INC. | $96.54 | 2020-2025 | Inhance, Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $48.08 | 2019 | |
| Emd Serono, INC. | $47.41 | 2019 | |
| Horizon Therapeutics Plc | $46.97 | 2020-2021 | |
| Linvatec Corporation | $41.32 | 2022 | |
| Motive Health, INC. | $30.31 | 2019 | |
| Orthofix Medical, INC. | $27.02 | 2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $17.01 | 2021 | |
| Organogenesis INC. | $14.85 | 2020 | |
| Si-Bone, INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,068,405.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.